32 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27089209	50	Discovery and analgesic evaluation of 8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione as a novel potent d-amino acid oxidase inhibitor.	Shanghai Jiao Tong University
26965861	15	D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.	Johns Hopkins University
26322531	73	Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.	Kitasato University
26309148	43	6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.	Johns Hopkins University
25408840	2	Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors.	Johns Hopkins University
23683589	21	Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.	Johns Hopkins University
23631755	37	Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.	Sunovion Pharmaceuticals
23540955	24	Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.	Astellas Pharma
23566269	90	4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.	Astellas Pharma
23391306	75	Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.	Kitasato University
23337801	24	Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.	Astellas Pharma
23243487	65	Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase.	TBA
22595173	68	The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).	Pharmaxis
21880399	35	Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.	Abbott Healthcare Products
18455394	34	The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.	Merck Sharp & Dohme
31580073	92	Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.	Pharmaxis
30265959	29	Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.	Tokushima University
29699925	5	Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.	Hungarian Academy of Sciences
29472125	20	Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.	Hungarian Academy of Sciences
16530804	4	3-Amidoquinuclidine derivatives: synthesis of compounds and inhibition of butyrylcholinesterase.	University of Zagreb
2537663	10	1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.	Stanford University
20455574	9	Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.	The Weizmann Institute of Science
14613321	28	Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors.	Aventis Pharma